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	Introduction	
	
The	various	aspects	that	comprise	metabolic	syndrome	such	as	pre-diabetes,	
dyslipidemia	and	pre-hypertension	epitomize	prodromal	phases	of	severe	cardiometabolic	
disorders.1	Lifestyle	modifications	have	demonstrated	the	ability	to	mitigate	or	arrest	the	
subsequent	advancement	of	various	components	of	metabolic	syndrome.	The	cardio	protective	
benefits	of	the	adoption	of	the	Mediterranean	diet	have	been	well	established	in	the	medical	
literature.	But	can	this	supposed	panacea	be	more	effective	in	preventing	the	progression	from	
pre-diabetes	to	type	2	diabetes	than	traditional	pharmacological	interventions	such	as	the	use	
of	Metformin?	That	is	what	this	paper	will	endeavor	to	ascertain.	
	
Adherence	to	the	Mediterranean	diet	has	been	touted	as	the	most	ideal	way	to	
maintain	overall	good	health	and	prevent	the	onset	of	certain	disease	processes.	2	However	the	
traditional	Mediterranean	diet	usually	referenced	in	academic	literature	is	not	a	distinct	or	
unique	diet,	it	is	in	fact	an	amalgamation	of	dietary	patterns	adhered	to	by	the	various	
populations	of	the	numerous	countries	that	lay	on	the	verge	of	the	Mediterranean	Sea.	The	diet	
points	to	a	nutritional	pattern	readily	accessible	in	the	Mediterranean	in	the	1960’s	that	
includes	complex	carbohydrates,	vegetables,	fruits,	legumes,	with	olive	oil	as	the	primary	
source	of	fats	and	low	to	moderate	amounts	red	wine	and	lean	animal	protein	such	as	chicken	
&	fish.2	Adherence	to	this	dietary	practice	has	been	shown	to	lower	the	probability	of	onset	of	
chronic	diseases	and	lower	the	risk	of	mortality	in	various	extensive	epidemiological	studies.2	
	Pathophysiology		
A	diagnosis	pre-diabetes	indicates	impaired	glucose	tolerance	(IGT)	along	with	impaired	
fasting	glucose	(IFG).	Together	they	represent	a	transitional	stage	with	diabetes	on	one	end	of	
the	spectrum	and	normal	glucose	tolerance	on	the	other.1	IGT	is	characterized	with	a	plasma	
glucose	reading	of	140-199	mg/dl	2	hours	after	consumption	of	75	gm	oral	glucose	solution,	IFG	
is	characterized	with	a	fasting	plasma	glucose	of	100-125	mg/dl.1	IGT	&	IFG	give	patients	an	
increased	probability	of	advancement	to	type	2	diabetes.		
	
The	development	and	full	manifestation	of	type	2	diabetes	is	in	and	of	itself	a	seminal	
event	but	it	also	increases	the	probability	and	severity	of	certain	other	disease	processes;	
namely	being	in	a	pre-diabetic	state	raises	one’s	risk	for	cardiovascular	disease.	If	one	then	
advances	to	an	established	diagnosis	of	type	2	diabetes	there	is	an	associated	increased	
probability	of	stroke,	CVD	and	peripheral	vascular	disease	in	comparison	with	patients	w/o	the	
same	disease	burden	in	the	general	population.1	There	appears	to	be	a	corollary	relationship		
between	macrovascular	disease	and	the	state	of	pre-diabetes,	many	patients	that	display	
hypertriglyceridemia,	hypertension,	insulin	resistance,	lowered	HDL	cholesterol	and	upper	body	
obesity	are	pre-diabetic	even	if	they	do	not	carry	that	official	diagnosis.1	The	constellation	of	
signs	and	symptoms	of	metabolic	syndrome	can	be	seen	concurrently	or	retroactively	before	an	
official	diagnosis	of	Type	2	DM	is	made.1	(All	issue	of	metabolic	syndrome	can	be	mitigated	with	
Med	Diet)	
Metabolic	Syndrome		
		
	
Persistent	over	abundance	of	the	body’s	primary	fuel	source	glucose	is	the	main	
pathogenic	circumstance	that	leads	to	the	development	of	type	2	diabetes	mellitus	in	persons	
who	are	genetically	or	more	importantly	epigenetically	predisposed	to	presentation	of	this	
disease	state.	3	However	not	all	people	who	are	overweight	and	whose	caloric	intake	exceeds	
daily	requirements	develop	type	2	diabetes.	In	some	the	glucose	intolerance	remains	minimal	
or	non	existent,	and	some	people	store	the	extra	energy	consumed	in	the	form	of	
subcutaneous	adipose	tissue	as	opposed	to	having	it	deposited	to	the	pancreas,	liver,	heart,	
skeletal	muscles.	This	is	due	to	a	compensatory	mechanisms	of	the	islet	B-cells	that	keep	blood	
nutrient	levels	within	normal	range	i.e.	blood	glucose	levels,	nominal	accrual	of	liver	fat,	lower	
amounts	of	visceral	adipose	tissue	as	opposed	to	subcutaneous	adipose	tissue	and	the	limited	
presence	of	insulin	resistance.	3	Through	these	compensatory	factors	vital	organ	systems	do	not	
undergo	longer	term	damage.	
	
In	individuals	who	go	on	to	develop	type	2	diabetes	the	aforementioned	compensatory	
are	hindered,	minimally	present	or	absent	all	together.	When	combined	with	other	metabolic	
factors-the	evolution	of	tangential	resistance	to	insulin,	systemic	inflammation	of	adipose	
tissue,	elevated	glucagon	secretion	and	lowered	incretin	reaction,	elevated	internal	glucose	
production	the	failure	of	the	islet	B-cells	to	indemnify	for	surplus	glycogen	inexorably	leads	to	
the	development	of	diabetes	mellitus	may	occur.		
	
Epidemiology		
The	approximated	prevalence	of	diabetes	in	adults	worldwide	was	285	million	in	2010.		
Striking	are	the	projections	that	this	figure	is	forecasted	to	increase	by	an	estimated	154	million	
by	2030.3	Type	2	diabetes	is	by	far	the	most	common	form	encompassing	almost	90%	of	cases.	
The	increase	is	estimated	to	be	much	more	drastic	in	2nd	and	3rd	world	nations.	This	sharp	rise	
in	the	prevalence	of	type	2	diabetes	is	no	doubt	connected	to	the	these	developing	countries	
increased	rates	of	obesity	linked	to	the	gradual	adoption	of	what	some	would	term	a	traditional	
western	diet.3		
	
Twenty	to	thirty	years	ago	the	incidence	of	type	2	diabetes	mellitus	was	unusual	in	
developing	countries,	and	in	the	most	populated	country	in	the	world	China	the	proportion	was	
estimated	to	be	less	than	1%.4	However	a	large	percentage	of	the	burden	of	future	cases	will	
not	be	incurred	by	developed	western	countries,	but	by	developing	countries	in	Asia	and	the	
Middle	East,	with	only	20%	of	cases	of	type	2	diabetes	occurring	in	the	developed	world.	The	
causes	of	this	are	multifactorial.	In	Asia	the	primary	causal	agents	are	increased	urbanization	
driven	by	robust	economic	development	which	in	turn	has	led	to	a	change	in	traditional	dietary	
trends	i.e.	shift	toward	a	more	western	diet	with	higher	proportions	of	meat,	processed	foods	
and	saturated	fat.	4	
	
Type	2	Diabetes	is	becoming	the	preeminent	chronic	disease	of	our	time,	diabetes	is	the	
primary	cause	for	non-traumatic	limb	amputation,	end	stage	renal	failure	and	blindness	along	
with	being	the	main	driver	of	increased	incidence	of	CVD,	heart	disease	and	PVD	as	previously	
noted.	1	Polycystic	ovarian	syndrome	and	non-alcoholic	fatty	liver	disease	have	also	been	linked	
to	type	2	diabetes.	3	
	
	
	
Financial	&	Pub	Health	Implications	
	
With	the	current	status	of	Type	2	Diabetes	Mellitus	as	“Primus	Inter	Pares”	with	respect	
to	other	chronic	medical	conditions	and	the	preeminence	it	is	projected	attain	with	respect	to	
future	healthcare	expenditures	and	resources-it	is	worthwhile	to	explore	the	true	cost	of	this	
pervasive	disease	process.	
		
The	straightforward	costs	of	the	disease	burden	of	DM	in	the	form	of	increased	medical	
expenditures	is	well	known	and	somewhat	easier	to	quantify;	however,	the	hidden	costs	in	the	
form	of	diminished	quality	of	life,	diminished	work	productivity	and	career	analogous	absences	
are	less	well	known	but	often	not	taken	into	consideration	when	mitigation	measures	are	
considered	and	undertaken	at	a	macroeconomic	level.5	A	study	from	2007	by	the	American	
Diabetes	Association	estimated	an	increase	of		174	billion	dollars	in	expenditures	on	care	
related	to	diabetes	along	with	diminished	productivity.5	With	the	number	of	individuals	in	the	
US	living	with	type	2	DM	expected	to	increase	to	an	estimate	of	one	third	of	the	population	by	
2050	and	healthcare	spending	accounting	for	almost	18	percent	of	Gross	Domestic	Product	
(GDP)	or	3.2	trillion	dollars	it	is	easy	to	see	how	the	projected	increased	incidence	of	DM	and	
it’s	ancillary	problems	could	put	a	considerable	burden	not	only	on	the	US	healthcare	system	
but	on	the	entire	economy	as	a	whole.	56	
	
It	is	believed	that	those	living	with	Diabetes	Mellitus	tend	to	utilize	healthcare	resources	
at	a	higher	rate	than	persons	without	diabetes.	This	is	primarily	due	to	the	fact	that	diabetes	
raises	your	probability	of	ophthalmic,	renal,	cardiovascular,	neurological	and	peripheral	
vascular	complications.	The	price	of	treating	routine	medical	conditions	not	related	to	diabetes	
is	also	increased.5.	
	
The	ancillary	cost	of	diabetes	in	the	form	of	work	absenteeism,	inability	to	participate	in	
the	workforce	due	to	early	mortality	and	diabetes	related	disability,	diminished	productivity	at	
work	and	overall	reduction	in	quality	of	life	due	to	disease	burden	are	the	hidden	but	far	more	
pervasive	and	costly	consequences	of	this	chronic	illness.	5	Persons	with	diabetes	tend	to	lose	
more	work	days	than	those	who	do	not	have	diabetes.	This	is	due	primarily	to	treatment	of	
other	conditions	often	present	with	diabetics	such	as	hypertension,	hyperlipidemia	and	
increase	BMI.	The	loss	of	personal	autonomy	along	with	the	inability	to	work	due	to	disability	
associated	with	diabetic	complications	is	also	very	substantial	cost	borne	by	society	as	whole,	
nearly	70,000	lower	limb	amputations	are	done	each	year	due	to	complications	from	diabetes	
as	estimated	by	the	Centers	for	Disease	Control.	5	Premature	death	due	to	diabetes	is	not	only	
disagreeable	but	severely	limits	prospective	productivity	and	hidden	behind	the	supposed	
cause	of	many	of	these	deaths	is	diabetes	as	the	driving	force,	nearly	20%	of	cardiovascular	
disease	deaths	can	be	accredited		to	diabetes,7	nearly	60%	of	deaths	caused	by	renal	failure	and	
almost	30%	of	deaths	due	to	cerebrovascular	disease	can	be	accredited	to	diabetes.5	
	
The	approximated	cost	of	treatment	of	diabetes	for	2012	was	nearly	246	billion	dollars	
with	nearly	176	billion	dollars	accounting	for	direct	spending	on	care	associated	with	diabetes	
and	the	other	70	billion	dollars	attributed	to	premature	deaths,	reduced	productivity	and	those	
not	participating	in	the	workforce	due	to	sustained	disability	from	diabetic	disease	process	
complications.5	In	2012	43.1	million	inpatient	hospital	days	out	of	an	estimated	168	million	
were	spent	caring	for	patients	with	a	diagnosis	of	diabetes	type	1	or	2,	with	61%	of	those	days	
directly	correlated	with	diabetes	care.5	Nearly	50%	of	total	emergency	department	visits,	
provider	office	visits,	and	prescriptions	written	for	those	with	diabetes	are	in	some	manner	or	
another	ascribed	to	their	chronic	illness.	With	what	has	been	termed	the	“Greying	of	America”	
i.e.	the	percentage	of	person	greater	than	65	years	of	age	rapidly	rising	with	the	ensuing	
retirement	of	the	Baby	Boomer	generation	this	trend	in	healthcare	expenditure	will	not	only	
continue	to	climb	but	rise	exponentially	over	the	coming	decades.	Those	greater	than	the	age	
of	65	utilize	a	considerable	quantity	of	health	care	resources	and	with	an	increasing	number	of	
Americans	being	diagnosed	with	type	2	diabetes	the	problem	really	begins	to	come	into	focus.	5	
This	burden	will	be	shared	or	endured	depending	on	your	outlook	by	all	citizens	in	the	United	
State	since	the	brunt	of	these	cost	will	be	satisfied	through	Medicare,	on	average	those	with	
diabetes	tend	to	be	less	healthy	and	older	due	to	the	aforementioned	cultural	pressure	the	that	
is	to	be	put	on	our	healthcare	infrastructure	in	the	coming	decades.5	
	
	 Most	concerning	is	that	estimates	from	a	diabetes	study	10	years	prior	point	out	that	
healthcare	expenditures	connected	to	medical	states	associated	with	diabetes	and	its	
complications	along	with	generic	medical	issues	treated	inpatient	that	are	not	associated	with	
diabetes	end	up	requiring	a	more	protracted	hospital	stays	irrespective	of	the	circumstances	of	
admission.5	In	addition	to	more	than	a	third	of	outpatient	and	physician	office	visits	that	list	
diabetes	as	the	primary	diagnosis	being	addressed,	this	ends	up	consuming	23%	of	an	
estimated	$1.5	trillion	in	total	healthcare	spending	according	to	most	recent	estimates.			
	
Methods		
A	Google	Scholar	search	was	done	utilizing	the	terms	diabetes	prevention	with	diet,	
Mediterranean	diet	for	prevention	of	diabetes,	diabetes	prevention	study,	prevention	of	
diabetes	with	diet	vs	medication.	Supplementary	terms	used	were	economic	cost	of	diabetes,	
worldwide/national	cost	of	diabetes,	GDP	percentage	used	to	treat	diabetes,	teaching	kitchens	
for	diabetes	care,	chronic	complications	of	diabetes.	The	same	terms	were	used	to	search	
PubMed.		
Results	
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Author/year		 Sample	Size		 Objective		 Follow-Up		 Sex		 Components		 Key	Findings	
Estruch	et	al,	2013	
Primary	
prevention	of	
Cardiovascular	
disease	with	
Mediterranean	
Diet		
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adherence	to	
Mediterranean	
Diet	is	inversely	
related	to	
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diagnosed	
type	2	
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in	Attica,	Greece	
adherence	to	
Mediterranean	
diet	was	assed	
using	
questionnaire	by	
healthcare	
professionals	and	
assigned	diet	
score		
Med	diet	led	
to	reduction	
in	systemic	
inflammation		
Diabetes	
Prevention	
Program	Research	
Group	2009,	10	Yr	
follow	up	
outcome	study		
3150	 Follow	up	with	
those	assigned	to	
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of	type	2	diabetes	
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intervention	
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Prevention	
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more	effective	in	
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as:	
-Weight	reduction		
-Increased	activity	
level		
-Low	far	diet			
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effective	than	
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Literature	Review		
	
Several	dietary	patterns	have	been	studied	by	nutritional	epidemiologists	with	regard	to	
development	or	prevention	of	type	2	diabetes	mellitus,	8	the	analysis	was	based	on	food	
frequency	questionnaires	of	those	studied	in	sizeable	cohorts.	8	It	distinguished	two	
considerable	dietary	patterns	that	correlate	to	ideal	and	non-ideal	health	outcomes,	the	first	
was	the	“Prudent	diet”.	The	prudent	diet	consists	of	poultry,	low-fat	dairy	products,	and	high	
volumes	of	fruit,	vegetables,	whole	grains,	legumes	and	fish.	8	The	second	was	the	“Western	
Diet”	consisting	of	high	fat	dairy	products,	and	high	volumes	of	sweets,	refined	grains,	eggs,	
processed	&	red	meat.	Their	analysis	showed	that	almost	all	dietary	behavioral	patterns	
correlated	to	diabetes	risk	are	encompassed	in	the	“western	diet”.	8	While	almost	all	the	
dietary	behavioral	patterns	associated	with	safeguards	against	the	development	of	diabetes	are	
encompassed	in	the	“prudent	diet”.	8	The	prudent	diet	has	many	of	the	hallmarks	of	the	
Mediterranean	diet	elucidated	earlier	in	this	text.	The	analysis	identified	a	third	dietary	pattern,	
the	Mediterranean	diet	which	as	mentioned	earlier	is	strikingly	similar	to	the	“prudent	diet”	but	
has	a	larger	monounsaturated	fatty	acid	content	due	to	incorporation	of	olive	oil	and	modest	
amounts	of	red	wine.	8.	I	surmise	that	the	incorporation	of	olive	and	red	wine	makes	this	option	
the	most	viable	and	appetizing	in	addition	to	gaining	some	modest	cardio	protective	effects	due	
to	the	red	wine	consumption.			
	
It	has	been	shown	from	prior	trials	that	newly	diagnosed	type	2	diabetes	patients	that	
are	put	on	a	Mediterranean	diet	with	lower	amounts	of	carbohydrates	are	more	likely	to	
remain	medication	free	for	longer	periods	of	time	than	those	without	said	diet	intervention.	9	In	
a	study	whose	primary	outcome	measure	was	initiation	of	medications	to	treat	diabetes	the	
data	stated	that	44%	of	patients	on	the	Mediterranean	diet	eventually	needed	medication	to	
regulate	hyperglycemia	while	70%	of	patients	who	were	assigned	a	simple	low-fat	diet	
eventually	required	medication.	9	With	the	entirety	those	in	the	low-fat	diet	group	taking	an	
average	of	6	years	to	arrive	and	need	for	medication	to	reduce	blood	glucose	levels	and	the	
entirety	of	those	in	the	Mediterranean	diet	group	taking	an	average	of	8	years	to	arrive	at	need	
for	medication	to	reduce	blood	glucose	levels.	9	The	incidence	of	return	to	a	state	of	glucose	
homeostasis	was	more	prevalent	in	the	Med	Diet	group	than	in	the	low-fat	diet	group	although	
it	was	minimal	between	both	groups	0.9%	in	the	low-fat	group	compared	to	4.6%	in	the	Med	
diet	group.		
	
Discussion	
	
All	this	brings	us	back	to	the	question	at	hand	which	is:	What	are	the	certain	lifestyle	
interventions	effective	at	preventing	the	onset	or	progression	from	a	pre-diabetic	or	impaired	
glucose	tolerance	state	to	full	blown	diabetes.	The	most	efficacious	diet	for	promoting	optimal	
health	and	inhibiting	the	onset	of	disease	has	extensively	been	documented	to	be	
Mediterranean	diet.2,9	A	meta-analysis	suggests	that	adherence	to	the	Mediterranean	diet	
offers	compellingly	powerful	protection	from	the	genesis	of	various	significant	chronic	
degenerative	diseases.2	In	somewhat	more	quantifiable	terms	a	2	point	increase	in	fidelity	to	
the	Mediterranean	diet	lowered	the	frequency	of	neurodegenerative	disease	by	13%,	lowered	
incidences	of	cerebrovascular	disease	by	10%,	lowered	occurrence	of	neoplastic	disease	by	6%	
with	an	overall	decrease	in	mortality.	2	
	
A	constant	state	of	global	inflammation	appears	to	influence	the	pathophysiology	of	a	
suite	of	disease	states	including	type	2	diabetes	mellitus.	10	In	a	study	from	2005	the	authors	
theorize	that	the	therapeutic	and	preventative	nature	of	the	Mediterranean	Diet	might	be	
attributed	to	its	capacity	to	regulate	and	reduce	certain	coagulation	properties	along	with	
global	inflammatory	response.10	
	
The	most	paramount	modifiable	risk	factor	that	drives	the	development	of	diabetes	is	
surplus	body	weight.	8	The	frequency	of	diabetes	is	directly	related	to	the	increase	in	obesity.	
Thus	loosing	excess	weight	or	not	gaining	weight	to	begin	with	can	be	a	powerful	panacea	to	
prevent	the	onset	of	type	2	diabetes.	8	In	spite	of	their	less	than	staller	results	over	the	
extended	course	of	the	disease,	treatment	with	drugs	that	promote	weight	loss	in	addition	to	
lowered	blood	sugar	levels	have	been	shown	to	have	salubrious	effects	correlated	to	glycemic	
control,	insulin	sensitivity,	and	overall	diabetes	risk.	8	Which	begs	the	question	why	not	just	
forgo	gaining	excess	weight	in	the	first	place?	The	inverse	relationship	between	weight	gain	and	
physical	activity	and	thus	development	of	diabetes	mellitus	is	well	documented	and	doesn’t	
need	to	be	expounded	upon.	However,	it	is	my	belief	that	with	the	increased	sedentary	lifestyle	
being	led	by	not	only	Americans	but	industrialized	countries	the	world	over,	weight	control	
through	diet	does	not	receive	the	amount	of	attention	warranted	with	respect	to	its	ability	to	
improve	overall	health	and	wellness.		
	
I	summation	it	has	been	demonstrated	that	a	traditional	Mediterranean	diet	that	
consists	of	low	consumption	of	high	fat	diary,	meat,	and	sweets;	moderate	consumption	of	fish,	
red	wine;	and	high	consumption	of	fruits,	vegetables,	whole	grains,	nuts,	and	olive	oil		is	
optimum	for	maintenance	of	overall	health	and	prevention	of	chronic	disease.	8	There	are	some	
distinct	attributes	of	the	to	the	Mediterranean	diet:	sauce	derived	from	tomato,	garlic,	onion,	
pepper	etc.	for	preparation	of	meals,	consumption	of	wine	in	modest	amounts,	and	copious	
volumes	of	olive	oil	extra	virgin	or	otherwise.8	This	abundance	of	olive	oil	helps	promote	the	
consumption	of	more	vegetables	as	it	used	to	produce	emulsions	and	other	dressing	to	make	
them	more	palatable.8	New	and	forthcoming	data	support	a	diet	such	as	the	Mediterranean	
diet	that	derives	a	minimum	of	1/3	of	its	total	calories	from	good	fat	sources	(nuts	&	olive	oil)	
can	assist	in	the	prevention	of	type	2	diabetes	mellitus	in	the	general	population	as	well	as	
those	who	have	been	given	a	diagnosis	of	pre-diabetes.8		
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